Publication | Open Access

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial

Alzheimer's DiseasePsychiatryDementiaNeuropsychiatryNeuropharmacologyNeurofibromatosis Type 1Cognitive DeficitsNeuroscienceNeurologyPlacebo-controlled TrialBrain PathologyMedicineHealth Sciences